PYXIS ONCOLOGY, INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • November 1st, 2022 • Pyxis Oncology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 1st, 2022 Company Industry JurisdictionPyxis Oncology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Securities LLC (the “Agent”), as follows: